TTK Prestige Q4 Results: Margins expand as profitability returns; Stock rises
TTK Prestige’s March quarter EBITDA margin expanded by 140 basis points to 9.2% from 7.8% in the year-ago period.
admin
Info Edge Q4 Results: Stock jumps on margin expansion, market share gains
Info Edge reported strong Q4 earnings with profit rising 22% and margins improving sharply, while 99acres turned EBIT positive and both 99acres and Jeevansathi continued gaining market share.
Max Healthcare shares slide 7% on subdued Q4 performance, lead Nifty 50 losses
The Competition Commission of India has issued directions for closure of 10-year old anti-competition proceedings against the 12 major hospitals, half of which are from the Max Chain.
The rupee may be overcooked from the West Asia heat
One estimate projects a $349 billion shield emerging out of the recent rout in the Indian currency.
LG Electronics India shares continue fall from post-listing high but remains a near-consensus ‘buy’
Shares of LG Electronics India are trading 3.2% lower on Friday at ₹1,480.7. The stock is down 8% in the last one month and has also turned negative on a year-to-date basis. The stock is also down 14% from its…
MTAR Technologies shares extend rally after ₹467 crore order; shares up 398% in a year
Last week, MTAR Tech raised its FY27 revenue growth guidance to 80% from 50% earlier, led by strong order inflows from the clean energy segment and improving operating leverage.
Buyback boom gains pace as firms deploy excess cash; tech, pharma may lead: Equirus Capital
Bhavesh Shah, Managing Director and Head of Investment Banking at Equirus Capital, expects cash-rich companies, particularly in the technology and pharma sectors, to lead the next wave of buybacks, while promoter taxation could shape capital allocation decisions.
Explained – Why Aurobindo Pharma shares are trading with losses of over 5% on Friday
Aurobindo Pharma, in a post-earnings conference call, said it sees its EBITDA margin improving to more than 21% in FY27. It said $400 million is a reasonable base assumption for the US business compared to $387 million in the fourth…
Alembic Pharma gets USFDA nod for thyroid disorder and cancer treatment drug
Alembic Pharmaceuticals gets USFDA nod for Levothyroxine Sodium Tablets, used as replacement therapy for congenital or acquired hypothyroidism and are also indicated as an adjunct treatment in certain thyroid cancer cases. This boosts Alembic Pharma’s ANDA tally to 239.
Q4 Results LIVE Updates: Max Health shares decline 7%, Honasa Consumer up 7%; Hindalco report today
Q4 Results Live Update: Another busy earnings week ends with three Nifty names – Sun Pharma, Eicher Motors and Hindalco reporting their results today, along with broader market names like Torrent Pharma, Fortis Healthcare, DAM Capital, Colgate-Palmolive, IRCON International, Jubilant…